Trader consensus on Polymarket prices a 75.5% implied probability for the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to an outbreak—by December 31, driven by escalating H5N1 avian influenza risks and recent near-misses with other pathogens. CDC surveillance reports over 70 U.S. human H5N1 cases since 2024, mostly among exposed dairy and poultry workers, with genetic mutations raising spillover concerns despite low person-to-person transmission to date; undetected infections via serology in veterinarians signal underreporting. The May 8 hantavirus outbreak on MV Hondius cruise ship prompted CDC's Level 3 Emergency Operations Center activation for monitoring disembarked U.S. passengers, underscoring rapid-response triggers. High seasonal influenza activity, with 155 pediatric deaths in the 2025-2026 season, adds epidemiological pressure; weekly FluView updates and WHO collaborations will clarify trajectories ahead.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-updateCDC issues Level 3 warning by December 31?
CDC issues Level 3 warning by December 31?
$117,078 Vol.
$117,078 Vol.
Dec 31, 2026
$117,078 Vol.
$117,078 Vol.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket prices a 75.5% implied probability for the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to an outbreak—by December 31, driven by escalating H5N1 avian influenza risks and recent near-misses with other pathogens. CDC surveillance reports over 70 U.S. human H5N1 cases since 2024, mostly among exposed dairy and poultry workers, with genetic mutations raising spillover concerns despite low person-to-person transmission to date; undetected infections via serology in veterinarians signal underreporting. The May 8 hantavirus outbreak on MV Hondius cruise ship prompted CDC's Level 3 Emergency Operations Center activation for monitoring disembarked U.S. passengers, underscoring rapid-response triggers. High seasonal influenza activity, with 155 pediatric deaths in the 2025-2026 season, adds epidemiological pressure; weekly FluView updates and WHO collaborations will clarify trajectories ahead.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Binuksan ang Market: Jan 19, 2026, 3:15 PM ET
Volume
$117,078Petsa ng Pagtatapos
Dec 31, 2026Binuksan ang Market
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket prices a 75.5% implied probability for the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to an outbreak—by December 31, driven by escalating H5N1 avian influenza risks and recent near-misses with other pathogens. CDC surveillance reports over 70 U.S. human H5N1 cases since 2024, mostly among exposed dairy and poultry workers, with genetic mutations raising spillover concerns despite low person-to-person transmission to date; undetected infections via serology in veterinarians signal underreporting. The May 8 hantavirus outbreak on MV Hondius cruise ship prompted CDC's Level 3 Emergency Operations Center activation for monitoring disembarked U.S. passengers, underscoring rapid-response triggers. High seasonal influenza activity, with 155 pediatric deaths in the 2025-2026 season, adds epidemiological pressure; weekly FluView updates and WHO collaborations will clarify trajectories ahead.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volume
$117,078Petsa ng Pagtatapos
Dec 31, 2026Binuksan ang Market
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus on Polymarket prices a 75.5% implied probability for the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to an outbreak—by December 31, driven by escalating H5N1 avian influenza risks and recent near-misses with other pathogens. CDC surveillance reports over 70 U.S. human H5N1 cases since 2024, mostly among exposed dairy and poultry workers, with genetic mutations raising spillover concerns despite low person-to-person transmission to date; undetected infections via serology in veterinarians signal underreporting. The May 8 hantavirus outbreak on MV Hondius cruise ship prompted CDC's Level 3 Emergency Operations Center activation for monitoring disembarked U.S. passengers, underscoring rapid-response triggers. High seasonal influenza activity, with 155 pediatric deaths in the 2025-2026 season, adds epidemiological pressure; weekly FluView updates and WHO collaborations will clarify trajectories ahead.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update
Mag-ingat sa mga external link.
Mag-ingat sa mga external link.
Mga Madalas na Tanong